Trans children who took puberty-blocking drugs had mental health issues, UK study found
Fox News
Taking puberty-blocking drugs has been shown to cause mental health issues in trans children, according to a recent analysis from the University of Essex.
Sold under the brand name Trelstar, triptorelin is a gonadotropin-releasing hormone (GnRH) agonist that reduces the amount of certain hormones in the body. The new analysis determined that 34% of the trans youth experienced a decline in mental health while taking puberty blockers. "Not only our bodies, but our brains, function best with optimal hormone levels." Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
The original study, which came from NHS's Gender Identity Development Service (GIDS) at Tavistock and University College London Hospitals (UCLH) in 2021, analyzed 44 children between the ages of 12 and 15 who took puberty-blocking drugs.